• Kaleo under fire for price hikes on naloxone treatment biopharmadive
    November 22, 2018
    A Senate report released Sunday heightened scrutiny of a pricing and prescribing strategy used by Kaleo to hike the price of its opioid overdose reversal autoinjector more than 600% in less than three years.
PharmaSources Customer Service